Host-microbe interactions in lung disease and exacerbations

Thematic Poster
Chairs: S. Bartel (Groningen, Netherlands), A. Jha (Cambridge, United Kingdom), A. Faiz (Groningen, Netherlands), S. Baraldo (Padova (PD), Italy)

Analysis of the nasal microbiome in long-term survivors after lung transplantation with a good allograft function V. Ruiz (Barcelona, Spain), A. Mendoza (Barcelona, Spain), A. Santiago (Barcelona, Spain), B. Saez (Barcelona, Spain), M. Hernandez (London, United Kingdom), T. Pereira (Barcelona, Spain), R. Escobar (Barcelona, Spain), C. Berastegui (Barcelona, Spain), A. Sole (Valencia, Spain), F. Zurbano (Santander, Spain), M. De La Torre (Coruña, Spain), R. Laporta (Madrid, Spain), J. Redel (Cordoba, Spain), M. Pozuelo (Barcelona, Spain), S. Gomez (Barcelona, Spain), C. Manichanh (Barcelona, Spain), A. Roman (Barcelona, Spain)
Immunity status of community acquired pneumonia (CAP) young patients according concomitant cytomegalovirus persistence (CMVP) K. Chichirelo-Konstantynovych (Vinnytsya, Ukraine), L. Moroz (Vinnytsya, Ukraine), T. Konstantynovych (Vinnytsya, Ukraine)
Emergence of an immunosuppressive neutrophil phenotype during pneumococcal lung co-infection with influenza A virus H. Wang (Melbourne, Australia), S. Bozinovski (Melbourne, Australia)
COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort A. Tovchigrechko (Gaithersburg, United States of America), C. Chiang (Gaithersburg, United States of America), D. Khatry (Gaithersburg, United States of America), C. Emson (Gaithersburg, United States of America), D. Singh (Manchester, United Kingdom), J. Wedzichia (London, United Kingdom), G. Donaldson (London, United Kingdom), C. Brightling (Leicester, United Kingdom), D. Finch (Gaithersburg, United States of America), O. Vaarala (Gaithersburg, United States of America)
Presence of airway SCFAs in asthma and response of airway epithelium to SCFAs M. Koliana (London, United Kingdom), E. Wong (London, United Kingdom), D. Jackson (London, United Kingdom), T. Kebadze (London, United Kingdom), C. Blanchard (Lausanne , Switzerland), S. Johnston (London, United Kingdom), E. Holmes (London, United Kingdom), G. Frost (London, United Kingdom)
Different inhaled corticosteroids altered lung microbiome and regulating the expression of PAF receptor as well as the phagocytosis function of macrophage Y. Chen (Douliu, Taiwan), H. Hou (Taipei, Taiwan), S. Cheng (Taipei, Taiwan), H. Wang (Taipei, Taiwan), C. Yu (Taipei, Taiwan)
IL-17RE/IL-17C mediate the recruitment of neutrophils during acute Streptococcus pneumoniae pneumonia P. Steck (Homburg, Germany), A. Honecker (Homburg, Germany), F. Ritzmann (Homburg, Germany), G. Vella (Homburg, Germany), C. Herr (Homburg, Germany), M. Bischoff (Homburg, Germany), T. Speer (Homburg, Germany), R. Bals (Homburg, Germany), C. Beisswenger (Homburg, Germany)
Characterization of the activity of the different oligomeric forms of pulmonary human surfactant protein SP-D R. Arroyo (Cincinnati, United States of America), M. Echaide (Madrid, Spain), E. Batllori (Madrid, Spain), A. Galindo (Madrid, Spain), F. Moreno-Herrero (Madrid, Spain), J. Pérez-Gil (Madrid, Spain), P. Kingma (Cincinnati, United States of America)
Cellular response to influenza infection:Lymphopenia and a reduced lymphocyte/monocyte ratio S. Punnilath Abdulsamad (Telford, United Kingdom), K. Bhatia (Telford, United Kingdom), H. Khalid (Telford, United Kingdom), A. Makan (Telford, United Kingdom), E. Crawford (Telford, United Kingdom), N. Ahmad (Telford, United Kingdom), K. Srinivasan (Telford, United Kingdom), H. Moudgil (Telford, United Kingdom)
Bronchial Lavage Exosome miRNA Correlates to Metabolic Disturbance in Patients with Pulmonary Acinetobacter Baumannii Infection B. Zhou (Xi'an, China), J. She (Xi'an, China)
BPI-fold containing Family A member 1 (Bpifa1) Role in IFN Driven Pulmonary Response S. Khanal (New Haven, United States of America), N. Niu (New Haven, United States of America), L. Sharma (New Haven, United States of America), W. Liu (New Haven, United States of America), L. Cohn (New Haven, United States of America), C. Dela Cruz (New haven, United States of America), C. Britto (New Haven, United States of America)
In silico investigation and comparative functional enrichment analysis of the human-respiratory syncytial virus (RSV) and the human-metapneumovirus (MPV) gene interaction networks. E. Rouka (Larissa, Greece), C. Hatzoglou (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), S. Zarogiannis (Larissa, Greece)
Antibody epitope and mimotope prediction of the viroporins M2 of the Influenza A virus, E of the Human SARS coronavirus and SH of the Respiratory Syncytial virus. E. Rouka (Larissa, Greece), C. Hatzoglou (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), S. Zarogiannis (Larissa, Greece)
LSC - 2019 - Interleukin-33: a double-edged sword in mast cell responses to rhinovirus infection C. Banas (Southampton, United Kingdom), C. Akoto (Southampton, United Kingdom), D. Davies (Southampton, United Kingdom), E. Swindle (Southampton, United Kingdom)
Assessment of the phagocytic capability of sputum macrophages and neutrophils in COPD patients. R. Gaskell (Manchester, United Kingdom), S. Hall (Stevenage, United Kingdom), B. Maschera (Stevenage, United Kingdom), A. Vitlic (Manchester, United Kingdom), E. Hessel (Stevenage, United Kingdom), D. Singh (Manchester, United Kingdom), S. Lea (Manchester, United Kingdom)
Co-expression Networks Analysis in Patients with Asthma and Healthy Controls Challenged with Rhinovirus A. Sinha (Amsterdam, Netherlands), X. Yu (Amsterdam, Netherlands), R. Lutter (Amsterdam, Netherlands), U. Frey (Basel, Switzerland), P. J. Sterk (Amsterdam, Netherlands), M. De Jong (Amsterdam, Netherlands), C. Cristella (Amsterdam, Netherlands)
Differential roles of B and CD4/CD8 T cells in S. aureus-driven lung lymphoid neogenesis L. Regard (Paris, France), C. Martin (Paris, France), H. Lafoeste (Paris, France), J. Teillaud (Paris, France), S. Siberil (Paris, France), P. Burgel (Paris, France)
Tumour necrosis factor and signal transducer and activator of transcription 3 pathways; novel targets to treat severe influenza virus infection P. Pandey (Hobart, Australia), A. Flies (Hobart, Australia), B. Lyons (Hobart, Australia), G. Karupiah (Hobart, Australia)
IL-17C associates with disease severity during acute exacerbation of chronic obstructive disease and promotes neutrophilic lung inflammation G. Vella (Homburg, Germany), F. Ritzmann (Homburg, Germany), C. Herr (Homburg, Germany), L. Wolf (Homburg, Germany), R. Bals (Homburg, Germany), C. Beisswenger (Homburg, Germany)
Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels I. Haaland (Bergen, Norway), S. Tangedal (Bergen, Norway), R. Nielsen (Bergen, Norway), M. Aanerud (Bergen, Norway), P. Bakke (Bergen, Norway), T. Eagan (Bergen, Norway)